PGS Sample Set (PSS) large_stringlengths 9 9 | Polygenic Score (PGS) ID large_stringlengths 9 2.77k | Number of Individuals int64 1 5.33M | Number of Cases float64 0 389k ⌀ | Number of Controls float64 0 1.14M ⌀ | Percent of Participants Who are Male float64 0 100 ⌀ | Sample Age large_stringclasses 733
values | Broad Ancestry Category large_stringclasses 73
values | Ancestry (e.g. French, Chinese) large_stringclasses 90
values | Country of Recruitment large_stringclasses 140
values | Additional Ancestry Description large_stringclasses 131
values | Phenotype Definitions and Methods large_stringclasses 798
values | Followup Time large_stringclasses 141
values | GWAS Catalog Study ID (GCST...) large_stringclasses 8
values | Source PubMed ID (PMID) float64 1.25M 39.9M ⌀ | Source DOI large_stringclasses 13
values | Cohort(s) large_stringclasses 460
values | Additional Sample/Cohort Information large_stringclasses 245
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSS000413 | PGS000320 | 206,612 | null | null | 100 | mean:57.0;sd:8.1;unit:years | European | null | null | null | All phenotypic data used for analyses were collected at the baseline visit. We provide a brief description here; more details can be found in S1 Text and elsewhere [18–21]. BMI, calculated as weight (kg) divided by height squared (m2), was used to categorize individuals with underweight (BMI < 18.5 kg/m2), normal weigh... | null | null | null | null | UKB | null |
PSS000413 | PGS000320 | 244,896 | null | null | 0 | mean:57.0;sd:7.9;unit:years | European | null | null | null | All phenotypic data used for analyses were collected at the baseline visit. We provide a brief description here; more details can be found in S1 Text and elsewhere [18–21]. BMI, calculated as weight (kg) divided by height squared (m2), was used to categorize individuals with underweight (BMI < 18.5 kg/m2), normal weigh... | null | null | null | null | UKB | null |
PSS000421 | PGS000321, PGS000322, PGS000323 | 28,640 | null | null | 0 | null | European | null | UK | null | Blood testosterone levels (UKB field 30850). Individuals taking the following testosterone-related drugs (methyltestosterone, finasteride, dutasteride, testosterone, mesterolone, and cyproterone) were excluded. | null | null | null | 10.1038/s41586-018-0579-z | UKB | null |
PSS000422 | PGS000321, PGS000322, PGS000323 | 28,601 | null | null | 100 | null | European | null | UK | null | Blood testosterone levels (UKB field 30850). Individuals taking the following testosterone-related drugs (methyltestosterone, finasteride, dutasteride, testosterone, mesterolone, and cyproterone) were excluded. | null | null | null | 10.1038/s41586-018-0579-z | UKB | null |
PSS000429 | PGS000324 | 3,020 | 66 | 2,954 | 51.45695 | null | European | null | USA | null | JIA diagnosis was made according to International League of Associations for Rheumatology standards (PMID:14760812) from EHR. Control subjects were unrelated and disease-free children. | null | null | null | null | CHOP | null |
PSS000430 | PGS000325 | 3,157 | 203 | 2,954 | 49.19227 | null | European | null | USA | null | JIA diagnosis was made according to International League of Associations for Rheumatology standards (PMID:14760812) from EHR. Control subjects were unrelated and disease-free children. | null | null | null | null | CHOP | null |
PSS000431 | PGS000326 | 3,089 | 135 | 2,954 | 50.11331 | null | European | null | USA | null | JIA diagnosis was made according to International League of Associations for Rheumatology standards (PMID:14760812) from EHR. Control subjects were unrelated and disease-free children. | null | null | null | null | CHOP | null |
PSS000432 | PGS000324 | 594 | 16 | 578 | 58.58586 | null | European | null | Australia | null | Diagnosis of JIA by a paediatric rheumatologist. | null | null | 23,153,063 | null | CLARITY | Cohort description (PMID): 23153063 |
PSS000433 | PGS000325 | 737 | 159 | 578 | 51.15332 | null | European | null | Australia | null | Diagnosis of JIA by a paediatric rheumatologist. | null | null | 23,153,063 | null | CLARITY | Cohort description (PMID): 23153063 |
PSS000434 | PGS000326 | 653 | 75 | 578 | 54.82389 | null | European | null | Australia | null | Diagnosis of JIA by a paediatric rheumatologist. | null | null | 23,153,063 | null | CLARITY | Cohort description (PMID): 23153063 |
PSS000435 | PGS000327 | 7,148 | 2,615 | 4,532 | null | mean (age at diagnosis):10.0;range:[10.0,14.0];unit:years | European | null | Denmark | null | Cases were selected from the iPSYCH sample as those diagnosed with ASD in 2013 or earlier by a psychiatrist according to ICD10, including diagnoses of childhood autism (ICD10 code F84.0), atypical autism (F84.1), Asperger’s syndrome (F84.5), other pervasive developmental disorders (F84.8), and pervasive developmental d... | null | null | null | null | iPSYCH | Average case/control numbers of each fold used in cross-validation (1/5th of total iPSYCH). |
PSS000436 | PGS000328 | 3,803 | 1,001 | 2,802 | null | null | European | null | Sweden | null | The discovery cohort included 1001 patients from the University clinics in Uppsala, Linköping, Karolinska Institute (Stockholm), Lund, and from the four northern-most counties in Sweden. All subjects fulfilled ≥4 ACR-82 classification criteria for SLE and were of European descent.30 Clinical data were collected from th... | null | null | null | null | Karolinska|UHU | The discovery cohort included 1001 patients from the University clinics in Uppsala, Linköping, Karolinska Institute (Stockholm), Lund, and from the four northern-most counties in Sweden |
PSS000437 | PGS000328 | 1,001 | 1,001 | 0 | null | null | European | null | Sweden | null | The discovery cohort included 1001 patients from the University clinics in Uppsala, Linköping, Karolinska Institute (Stockholm), Lund, and from the four northern-most counties in Sweden. All subjects fulfilled ≥4 ACR-82 classification criteria for SLE and were of European descent.30 Clinical data were collected from th... | null | null | null | null | Karolinska|UHU | The discovery cohort included 1001 patients from the University clinics in Uppsala, Linköping, Karolinska Institute (Stockholm), Lund, and from the four northern-most counties in Sweden |
PSS000438 | PGS000328 | 15,383 | 5,524 | 9,859 | null | null | European | null | NR | null | null | null | null | 28,714,469 | null | null | The replication cohort is described in Langefeld et al. (PMID:28714469) |
PSS000439 | PGS000331 | 10,561 | 229 | 10,332 | 47.3 | mean (age at baseline):48.0;unit:years | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FINRISK | FINRISK surveys from 1992, 1997, 2002 and 2007 |
PSS000440 | PGS000329 | 20,165 | 1,209 | 18,956 | 47.3 | mean (age at baseline):48.0;unit:years | European | Finnish | Finland | null | Coronary heart disease was defined as Myocardial infarction|Myocardial infarction, strict|Complications following myocardial infarction|Prior myocardial infactrion|Angina pectoris|Other coronary atherosclerosis|Coronary artery bypass graft**|Coronary angioplasty**. ICD9/10 codes are listed in Table S9. National registr... | null | null | null | null | FINRISK | FINRISK surveys from 1992, 1997, 2002 and 2007 |
PSS000441 | PGS000330 | 21,030 | 1,346 | 19,684 | 47.3 | mean (age at baseline):48.0;unit:years | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FINRISK | FINRISK surveys from 1992, 1997, 2002 and 2007 |
PSS000442 | PGS000331 | 135,300 | 12,809 | 122,491 | 43.7 | mean (age at baseline):59.2;sd:16.6;unit:years | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000443 | PGS000332 | 76,173 | 4,960 | 71,213 | 0 | null | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000444 | PGS000332 | 37,841 | 742 | 37,099 | null | null | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000445 | PGS000329 | 135,300 | 20,179 | 115,121 | 43.7 | mean (age at baseline):59.2;sd:16.6;unit:years | European | Finnish | Finland | null | Coronary heart disease was defined as Myocardial infarction|Myocardial infarction, strict|Complications following myocardial infarction|Prior myocardial infactrion|Angina pectoris|Other coronary atherosclerosis|Coronary artery bypass graft**|Coronary angioplasty**. ICD9/10 codes are listed in Table S9. National registr... | null | null | null | null | FinnGen | null |
PSS000446 | PGS000333 | 59,126 | 3,617 | 55,509 | 100 | null | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000447 | PGS000333 | 48,851 | 1,172 | 47,679 | null | null | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000448 | PGS000330 | 135,300 | 17,519 | 117,781 | 43.7 | mean (age at baseline):59.2;sd:16.6;unit:years | European | Finnish | Finland | null | National registries were used to assess disease incidence. Follow-up ended at first-ever diagnosis of the disease of interest, death or at the end of follow-up on December 31, 2018, whichever came first. Disease endpoints are defined in Table S9. | null | null | null | null | FinnGen | null |
PSS000449 | PGS000334 | 847 | 216 | 631 | 54.7 | mean (cases):77.6;sd (cases):7.6;unit:years | European | null | Australia | null | null | null | null | null | null | ABIL | null |
PSS000449 | PGS000334 | 665 | 77 | 588 | 44.4 | mean (cases):86.8;sd (cases):4.6;unit:years | European | null | Australia | null | null | null | null | null | null | MAS | null |
PSS000449 | PGS000334 | 2,298 | 383 | 1,915 | 47 | mean (cases):64.4;sd (cases):4.5;unit:years | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS000450 | PGS000004, PGS000332, PGS000335 | 122,978 | 8,401 | 114,577 | 0 | mean age (at the end of follow-up):58.5;iqr:[45.1,72.2];unit:years | European | Finnish | Finland | null | Breast cancer cases were identified through the Finnish Cancer Registry with diagnosis C50 (International Classification of Diseases for Oncology, 3rd Edition; ICD-O-3), from the drug reimbursement registry by selecting individuals with a reimbursement code for breast cancer, and from the death registry with ICD-10 C50... | null | null | null | null | FinnGen | null |
PSS000451 | PGS000336 | 8,433 | 4,674 | 3,759 | 47.78 | null | European | Finnish | null | null | Chronotype was assessed using a singl self-evaluatation question from a shortend version of Horne and Ostber'gs MEQ (sMEQ) on chronotype. The sMEQ included 6 items (items 4,7,9,15,17 and 19) from the original MEQ. The answers were scored according to the scoring of the original MEQ. For the single self-evaluation que... | null | null | null | null | FINRISK | Included participants from the National FINRISK 2007 and 2012 studies |
PSS000452 | PGS000336 | 7,436 | 2,364 | 5,072 | 46.4 | null | European | Finnish | null | null | Chronotype was assessed using a shortend version of Horne and Ostberg's MEQ(sMEQ) . The sMEQ included 6 items (items 4,7,9,15,17 and 19) from the original MEQ. The answers were scored according to the scoring of the original MEQ. The sum score was used as a binary variable (evening type: socres from 5-15, morning typ... | null | null | null | null | FINRISK | Included participants from the National FINRISK 2007 and 2012 studies |
PSS000453 | PGS000336 | 7,436 | null | null | null | null | European | Finnish | null | null | Chronotype was assessed using a shortend version of Horne and Ostberg's MEQ(sMEQ) The sMEQ included 6 items (items 4,7,9,15,17 and 19) from the original MEQ. The answers were scored according to the scoring of the original MEQ. The sum score was used as a continuous variable (continuous sMEQ score). | null | null | null | null | FINRISK | Included participants from the National FINRISK 2007 and 2012 studies |
PSS000454 | PGS000337 | 49,230 | 9,816 | 39,414 | null | null | East Asian | Japanese | Japan | null | Cause of death under ICD-10 code | median:7.7;unit:years | null | null | null | BBJ | null |
PSS000455 | PGS000337 | 49,230 | 362 | 48,868 | null | null | East Asian | Japanese | Japan | null | Cause of death under ICD-10.CHF code | median:7.7;unit:years | null | null | null | BBJ | null |
PSS000456 | PGS000337 | 49,230 | 2,122 | 47,108 | null | null | East Asian | Japanese | Japan | null | Cause of death under ICD-10.I codes | median:7.7;unit:years | null | null | null | BBJ | null |
PSS000457 | PGS000337 | 49,230 | 464 | 48,766 | null | null | East Asian | Japanese | Japan | null | Cause of death under ICD-10.IHD code | median:7.7;unit:years | null | null | null | BBJ | null |
PSS000458 | PGS000337 | 49,230 | 1,193 | 48,037 | null | null | East Asian | Japanese | Japan | null | Cause of death under ICD-10.J codes | median:7.7;unit:years | null | null | null | BBJ | null |
PSS000459 | PGS000337 | 10,999 | 1,827 | 9,172 | 84 | null | East Asian | Japanese | Japan | null | CAD was defined as a composite of stable angina, unstable angina and myocardial infarction. The disease definitions are dependent on the physician's diagnosis based on general medical practices following relevant guidelines and according to the clinical symptoms and diagnotic tests. | null | null | null | null | BBJ | null |
PSS000460 | PGS000338 | 530 | 307 | 223 | null | null | European | null | null | null | Atrial fibrillation was defined as a clinical history of AF or atrial flutter (AFL) and/or AF(L) on baseline electrocardiogram. Patients were regarded as having sinus rhythm if they had no history of AF and sinus rhythm on baseline ECG. HFpEF defined as LVEF >/= 50% | null | null | null | null | BIOSTAT-CHF | BIOSTAT-CHF study included patients from 11 European countries. Patients from Scotland were included in the vaidation cohort between October 2010 and April 2014 |
PSS000461 | PGS000338 | 2,262 | 1,125 | 1,137 | null | null | European | null | null | null | Atrial fibrillation was defined as a clinical history of AF or atrial flutter (AFL) and/or AF(L) on baseline electrocardiogram. Patients were regarded as having sinus rhythm if they had no history of AF and sinus rhythm on baseline ECG.HFrEF defined as LVEF <40% | null | null | null | null | BIOSTAT-CHF | BIOSTAT-CHF study included patients from 11 European countries. Patients from Scotland were included in the vaidation cohort between October 2010 and April 2014 |
PSS000462 | PGS000338 | 3,759 | 1,976 | 1,783 | 70 | mean:72.8;sd:11.5;unit:years | European | null | null | null | Atrial fibrillation was defined as a clinical history of AF or atrial flutter (AFL) and/or AF(L) on baseline electrocardiogram. Patients were regarded as having sinus rhythm if they had no history of AF and sinus rhythm on baseline ECG. | null | null | null | null | BIOSTAT-CHF | BIOSTAT-CHF study included patients from 11 European countries. Patients from Scotland were included in the vaidation cohort between October 2010 and April 2014 |
PSS000463 | PGS000339 | 3,066 | 1,292 | 1,774 | 46.28 | null | European | null | null | Australia | Unaffected family members from families with increased melaona risk. Recruited families were ranked as low-, medium- or high-risk using a risk index (T) that factored in the number of confirmed cases of melanoma versus number of unaffected family members, ages and year of birth | null | null | null | null | QFMP|BATS | null |
PSS000464 | PGS000339 | 1,885 | 111 | 1,774 | 46.37 | null | European | null | null | Australia | Unaffected family members from families with increased melaona risk. Recruited families were ranked as low-, medium- or high-risk using a risk index (T) that factored in the number of confirmed cases of melanoma versus number of unaffected family members, ages and year of birth | null | null | null | null | QFMP|BATS | null |
PSS000465 | PGS000340 | 1,120 | null | null | 40.4 | mean:41.36;unit:years | European, NR | null | null | European (94%), Not reported (6%) | Individuals ≥18 years with clinically diagnosed heterozygous familial hypercholesterolemia (FH) from the BCFH cohort. Individuals who were positive for the common French Canadian variant in the LDLR gene including del.15 kb of the promoter and exon 1, del.5 kb of exons 2 and 3, p.W66G (exon 3), p.E207K (exon 4), p.Y468... | null | null | null | null | UKB|CNMA|BCFH | null |
PSS000466 | PGS000340 | 389,127 | null | null | null | null | European | null | null | null | Any atherosclerotic cardiovascular disease (ASCVD) event, which was defined as myocardial infarction, coronary artery disease or carotid revascularization, transient ischemic attack or stroke. For the UK Biobank, retrospecitvie ASCVD was self reported and prospective ASCVD were defined using hospital episode statistics... | null | null | null | null | UKB | null |
PSS000467 | PGS000013 | 28,556 | 4,122 | 24,434 | 38.7 | mean:57.9;unit:years | European, NR | null | null | European=28286, NR=270 | Individuals were free of CAD at time of enrollment. CAD was defined as (1)fatal or nonfatal myocardial infarction: defined based on either International Classification of Diseases, Ninth Revision (ICD-9) code 410 or Tenth Revision (ICD-10) code I21, (2)coronary artery bypass graft surgery: defined as procedure codes 30... | median:21.3;iqr:[16.1,23.1];unit:years | null | null | null | MDC | null |
PSS000468 | PGS000013 | 5,685 | 815 | 4,870 | 41.16 | null | European, NR | null | null | European=5640, NR=45 | Individuals were free of CAD at time of enrollment. CAD was defined as (1)fatal or nonfatal myocardial infarction: defined based on either International Classification of Diseases, Ninth Revision (ICD-9) code 410 or Tenth Revision (ICD-10) code I21, (2)coronary artery bypass graft surgery: defined as procedure codes 30... | median:23.2;iqr:[17.6,24.2];unit:years | null | null | null | MDC-CC | Cardiovascular Cohort |
PSS000469 | PGS000013 | 325,003 | 7,708 | 317,295 | 44.2 | mean:56.8;unit:years | European, African unspecified, South Asian, East Asian, NR | null | null | European=304270, African unspecified=5760, South Asian=6832, East Asian (Chinese)=1117, NR=7024 | Individuals were free of CAD at time of enrollment. CAD was defined based on hospitalisation with or death due to ICD-10 codes for acute or subsequent myocaridal infarction (I21, I22, I23, I24.1, and I25.2); or hospitalisation with ICD-9 codes for myocaridal. infarction (410, 411, and 412); or hospitalisation with OPCS... | median:8.1;iqr:[7.4,8.8];unit:years | null | null | null | UKB | null |
PSS000480 | PGS000004 | 25,531 | 12,133 | 13,398 | 0 | null | Asian unspecified | null | Canada, Japan, Hong Kong, Malaysia, USA, Korea, Singapore, Taiwan | null | Women (European Ancestry) diagnosed with unilateral breast cancer | null | null | null | null | CBCS|NC-BCFR|HERPACC|MYBRCA|SEBCS|SGBCC|TWBCS|HKBCS | null |
PSS000481 | PGS000004 | 12,473 | 340 | 12,133 | 0 | null | Asian unspecified | null | Canada, Japan, Hong Kong, Malaysia, USA, Korea, Singapore, Taiwan | null | Women (Asian Ancestry) diagnosed with unilateral breast cancer or CBC. CBC was defined as breast cancer (in situ or invasive) in the contralateral breast irrespective of the time since the first breast cancer. | null | null | null | null | CBCS|NC-BCFR|HERPACC|MYBRCA|SEBCS|SGBCC|TWBCS|HKBCS | null |
PSS000482 | PGS000004 | 84,607 | 3,607 | 81,000 | 0 | null | European | null | Australia, Netherlands, Germany, UK, USA, Ireland, Spain, Canada, Greece, Denmark, Finland, Belarus, Russia, Sweden, New Zeland, Belgium, Republic of North Macedonia, Italy, Norway, Poland | null | Women (European Ancestry) diagnosed with unilateral breast cancer or CBC. CBC was defined as breast cancer (in situ or invasive) in the contralateral breast irrespective of the time since the first breast cancer. | null | null | null | null | ABCFS|MCCS|HMBCS|LMBC|CGPS|KBCP|OBCS|BBCC|BSUCH|GENICA|MARIE|SKKDKFZS|BIGGS|ABCS|ORIGO|SZBCS|PBCS|pKARMA|SASBAC|SBCS|SEARCH|MCBCS|MEC|ABCTB|BBCS|BCEES|BCFR-NY|BCFR-PA|BCFR-UTAH|BREOGAN|CBCS|CCGP|CNIO-BCS|DIETCOMPLYF|GC-HBOC|GESBC|HEBCS|KARBAC|MABCS|MBCSG|MISS|MMHS|NBCS|NC-BCFR|OFBCR|POSH|PREFACE|RBCS|SUCCESSB|SUCCESSC|... | null |
PSS000483 | PGS000004 | 143,830 | 81,000 | 62,830 | 0 | null | European | null | Australia, Netherlands, Germany, UK, USA, Ireland, Spain, Canada, Greece, Denmark, Finland, Belarus, Russia, Sweden, New Zeland, Belgium, Republic of North Macedonia, Italy, Norway, Poland | null | Women (European Ancestry) diagnosed with unilateral breast cancer | null | null | null | null | ABCFS|MCCS|HMBCS|LMBC|CGPS|KBCP|OBCS|BBCC|BSUCH|GENICA|MARIE|SKKDKFZS|BIGGS|ABCS|ORIGO|NorBCS|SZBCS|PBCS|pKARMA|SASBAC|SBCS|SEARCH|MCBCS|MEC|ABCTB|BBCS|BCEES|BCFR-NY|BCFR-PA|BCFR-UTAH|BREOGAN|CBCS|CCGP|CNIO-BCS|DIETCOMPLYF|GC-HBOC|GESBC|HEBCS|KARBAC|MABCS|MBCSG|MISS|MMHS|NC-BCFR|OFBCR|POSH|PREFACE|RBCS|SUCCESSB|SUCCESS... | null |
PSS000484 | PGS000001, PGS000004, PGS000005, PGS000006 | 56,068 | 1,027 | 55,041 | 0 | median (age at diagnosis):56.0;unit:years | European | null | Australia, Netherlands, Germany, UK, USA, Ireland, Spain, Greece, Denmark, Finland, Sweden, Belgium, New Zeland, Republic of North Macedonia, Italy, Norway, Canada, Poland | null | Women (European Ancestry) diagnosed with unilateral breast cancer or metachronous contralateral breast cancer (CBC). Metachronous contralateral breast cancer was defined as breast cancer in the contralateral breast (in situ or invasive) diagnosed at least 3 months after the first breast cancer. | median:8.4;unit:years | null | null | null | ABCFS|LMBC|CGPS|OBCS|BBCC|BSUCH|GENICA|MARIE|SKKDKFZS|BIGGS|ABCS|ORIGO|SZBCS|PBCS|pKARMA|SASBAC|SBCS|SEARCH|MCBCS|MEC|ABCTB|AOCS|BCFR-PA|BREOGAN|CCGP|GC-HBOC|HEBCS|KARBAC|MABCS|MBCSG|MISS|NBCS|NC-BCFR|OFBCR|POSH|RBCS|UCIBCS|PROCAS|kConFab|ABCS-F|KARMA|HCSC | null |
PSS000485 | PGS000004, PGS000005 | 56,068 | 275 | 55,793 | 0 | median (age at diagnosis):56.0;unit:years | European | null | Australia, Netherlands, Germany, UK, USA, Ireland, Spain, Greece, Denmark, Finland, Sweden, Belgium, New Zeland, Republic of North Macedonia, Italy, Norway, Canada, Poland | null | Women (European Ancestry) diagnosed with unilateral breast cancer or metachronous contralateral breast cancer (CBC). Metachronous contralateral breast cancer was defined as breast cancer in the contralateral breast (in situ or invasive) diagnosed at least 3 months after the first breast cancer. | median:8.4;unit:years | null | null | null | ABCFS|LMBC|CGPS|OBCS|BBCC|BSUCH|GENICA|MARIE|SKKDKFZS|BIGGS|ABCS|ORIGO|SZBCS|PBCS|pKARMA|SASBAC|SBCS|SEARCH|MCBCS|MEC|ABCTB|AOCS|BCFR-PA|BREOGAN|CCGP|GC-HBOC|HEBCS|KARBAC|MABCS|MBCSG|MISS|NBCS|NC-BCFR|OFBCR|POSH|RBCS|UCIBCS|PROCAS|kConFab|ABCS-F|KARMA|HCSC | null |
PSS000486 | PGS000001, PGS000004, PGS000005, PGS000006 | 56,068 | 923 | 55,145 | 0 | median (age at diagnosis):56.0;unit:years | European | null | Australia, Netherlands, Germany, UK, USA, Ireland, Spain, Greece, Denmark, Finland, Sweden, Belgium, New Zeland, Republic of North Macedonia, Italy, Norway, Canada, Poland | null | Women (European Ancestry) diagnosed with unilateral breast cancer or metachronous contralateral breast cancer (CBC). Metachronous contralateral breast cancer was defined as breast cancer in the contralateral breast (in situ or invasive) diagnosed at least 3 months after the first breast cancer. | median:8.4;unit:years | null | null | null | ABCFS|LMBC|CGPS|OBCS|BBCC|BSUCH|GENICA|MARIE|SKKDKFZS|BIGGS|ABCS|ORIGO|SZBCS|PBCS|pKARMA|SASBAC|SBCS|SEARCH|MCBCS|MEC|ABCTB|AOCS|BCFR-PA|BREOGAN|CCGP|GC-HBOC|HEBCS|KARBAC|MABCS|MBCSG|MISS|NBCS|NC-BCFR|OFBCR|POSH|RBCS|UCIBCS|PROCAS|kConFab|ABCS-F|KARMA|HCSC | null |
PSS000489 | PGS000341 | 339 | null | null | null | null | European | Spanish | null | null | The diagnosttic criteria for each disease was based on gold-standard clinical guidelines. | null | null | null | null | PRECISESADS | null |
PSS000490 | PGS000342, PGS000343 | 543 | 140 | 403 | null | null | NR | null | USA | null | Cases included physician-confirmed psoriatic arthritis (PsA). Controls inclded individuals with psoriasis with no history of joint symptoms (psoriasis only - PsO). | null | null | null | null | null | null |
PSS000491 | PGS000344, PGS000345 | 32,238 | 15,755 | 16,483 | 0 | null | Asian unspecified | null | Thailand, Japan, China, Korea, Taiwan, Malaysia, Singapore | null | null | null | null | null | null | ACP|HERPACC|MYBRCA|SBCGS|SEBCS|SGBCC|TWBCS|HKBCS|KOHBRA|NagBCS | null |
PSS000492 | PGS000347 | 26,960 | 10,477 | 16,483 | 0 | null | Asian unspecified | null | Thailand, Japan, China, Korea, Taiwan, Malaysia, Singapore | null | null | null | null | null | null | ACP|HERPACC|MYBRCA|SBCGS|SEBCS|SGBCC|TWBCS|HKBCS|KOHBRA|NagBCS | null |
PSS000493 | PGS000346 | 21,247 | 4,764 | 16,483 | 0 | null | Asian unspecified | null | Thailand, Japan, China, Korea, Taiwan, Malaysia, Singapore | null | null | null | null | null | null | ACP|HERPACC|MYBRCA|SBCGS|SEBCS|SGBCC|TWBCS|HKBCS|KOHBRA|NagBCS | null |
PSS000494 | PGS000344 | 10,392 | 5,236 | 5,156 | 0 | null | East Asian | Chinese | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000494 | PGS000344 | 2,416 | 1,084 | 1,332 | 0 | null | South East Asian | Malay | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000494 | PGS000344 | 1,598 | 580 | 1,018 | 0 | null | South Asian | Indian | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000495 | PGS000346 | 6,521 | 1,365 | 5,156 | 0 | null | East Asian | Chinese | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000495 | PGS000346 | 1,668 | 336 | 1,332 | 0 | null | South East Asian | Malay | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000495 | PGS000346 | 1,202 | 184 | 1,018 | 0 | null | South Asian | Indian | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000496 | PGS000347 | 8,783 | 3,627 | 5,156 | 0 | null | East Asian | Chinese | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000496 | PGS000347 | 2,047 | 715 | 1,332 | 0 | null | South East Asian | Malay | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000496 | PGS000347 | 1,392 | 374 | 1,018 | 0 | null | South Asian | Indian | Malaysia, Singapore | null | null | null | null | null | null | MYBRCA|SGBCC | null |
PSS000497 | PGS000344, PGS000345 | 2,719 | 1,507 | 1,212 | 0 | null | Asian unspecified | null | USA, Canada | null | null | null | null | null | null | NC-BCFR|LAABC|CanBCS | null |
PSS000498 | PGS000346 | 1,492 | 280 | 1,212 | null | null | Asian unspecified | null | USA, Canada | null | null | null | null | null | null | NC-BCFR|LAABC|CanBCS | null |
PSS000499 | PGS000347 | 2,234 | 1,022 | 1,212 | null | null | Asian unspecified | null | USA, Canada | null | null | null | null | null | null | NC-BCFR|LAABC|CanBCS | null |
PSS000500 | PGS000345 | 10,255 | 413 | 9,842 | 0 | null | East Asian | Chinese | Singapore | null | null | null | null | null | null | SCHS | null |
PSS000501 | PGS000348 | 3,891 | 1,972 | 1,919 | 100 | null | European | null | USA, NR | null | Cases: Male, self-reported European ancestry, greater or equal to 18 years of age at prostate cancer diagnosis. JHH cases were patients undergoing radical prostatectomy for the treatment of clinically localized PrCa in 2002 to 2015 and were included if disease was organ‐confined and Gleason score ≤6 or ≥8, as determine... | null | null | null | null | JHH|AG|NSGHI | null |
PSS000502 | PGS000348 | 1,039 | 744 | 295 | 100 | null | European | null | USA, NR | null | Cases: Male, self-reported European ancestry, greater or equal to 18 years of age at prostate cancer diagnosis. JHH cases were patients undergoing radical prostatectomy for the treatment of clinically localized PrCa in 2002 to 2015 and were included if disease was organ‐confined and Gleason score ≤6 or ≥8, as determine... | null | null | null | null | JHH|AG | null |
PSS000503 | PGS000348 | 2,305 | 1,133 | 1,172 | 100 | null | European | null | USA, NR | null | Cases: Male, self-reported European ancestry, greater or equal to 18 years of age at prostate cancer diagnosis. JHH cases were patients undergoing radical prostatectomy for the treatment of clinically localized PrCa in 2002 to 2015 and were included if disease was organ‐confined and Gleason score ≤6 or ≥8, as determine... | null | null | null | null | JHH|AG | null |
PSS000504 | PGS000349 | 4,041 | 343 | 3,698 | 47.5 | mean:58.9;sd:7.6;unit:years | European | null | Germany | null | Participants with no prior Coronary Heart Disease (CHD) at the time of enrollment were included within the present study. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. | median:11.6;sd:3.7;unit:years | null | null | null | HNR | null |
PSS000505 | PGS000349 | 4,041 | 2,734 | 1,307 | null | null | European | null | Germany | null | null | null | null | null | null | HNR | null |
PSS000506 | PGS000349 | 1,919 | 219 | 1,700 | 100 | null | European | null | Germany | null | Male participants with no prior Coronary Heart Disease (CHD) at the time of enrollment were included within the present study. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. | null | null | null | null | HNR | null |
PSS000507 | PGS000349 | 3,748 | 321 | 3,427 | null | null | European | null | Germany | null | Participants with no prior Coronary Heart Disease (CHD) at the time of enrollment were included within the present study. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. Cardiovascular risk factor data required included smo... | null | null | null | null | HNR | null |
PSS000508 | PGS000349 | 3,748 | 2,536 | 1,212 | null | null | European | null | Germany | null | null | null | null | null | null | HNR | null |
PSS000509 | PGS000349 | 2,560 | 278 | 2,282 | null | null | European | null | Germany | null | Participants with no prior Coronary Heart Disease (CHD) at the time of enrollment with coronary artery calcification>0 were included. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. Cardiovascular risk factor data required ... | null | null | null | null | HNR | null |
PSS000510 | PGS000349 | 1,765 | 202 | 1,563 | 100 | null | European | null | Germany | null | Male participants with no prior Coronary Heart Disease (CHD) at the time of enrollment were included within the present study. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. Cardiovascular risk factor data required include... | null | null | null | null | HNR | null |
PSS000511 | PGS000349 | 1,426 | 186 | 1,240 | 100 | null | European | null | Germany | null | Male participants with no prior Coronary Heart Disease (CHD) at the time of enrollment with coronary artery calcification>0 were included. Incidental CHD was the primary end-points of the study. CHD was defined as fatal and non-fatal myocardial infarction, stroke and coronary death. Cardiovascular risk factor data requ... | null | null | null | null | HNR | null |
PSS000512 | PGS000350 | 6,538 | 3,108 | 3,430 | 43.38 | null | European | null | null | null | A harmonized definition of POAG used the following criteria: (1) open anterior segment angles; (2) reproducible glaucomatous visual field loss on reliable tests; or (3) an eye with cup-disc ratio of at least 0.7 with 1 visual field showing glaucomatous loss; and (4) no identifiable secondary cause for optic nerve disea... | null | null | null | null | NEIGHBOR|GLAUGEN | null |
PSS000513 | PGS000350 | 2,947 | 2,947 | 0 | null | null | European | null | null | null | A harmonized definition of POAG used the following criteria: (1) open anterior segment angles; (2) reproducible glaucomatous visual field loss on reliable tests; or (3) an eye with cup-disc ratio of at least 0.7 with 1 visual field showing glaucomatous loss; and (4) no identifiable secondary cause for optic nerve disea... | null | null | null | null | NEIGHBOR|GLAUGEN | null |
PSS000514 | PGS000013 | 24,371 | 2,824 | 21,547 | 42.7 | mean:57.0;unit:years | European, Hispanic or Latin American, African unspecified | null | USA | African unspecified=6979, European=10344, Hispanic or Latin American=7048 | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | BioMe | null |
PSS000515 | PGS000013 | 6,979 | null | null | null | null | African unspecified | null | USA | null | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | BioMe | null |
PSS000516 | PGS000013 | 10,344 | null | null | null | null | European | null | USA | null | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | BioMe | null |
PSS000517 | PGS000013 | 7,048 | null | null | null | null | Hispanic or Latin American | null | USA | null | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | BioMe | null |
PSS000518 | PGS000013 | 13,667 | 3,538 | 10,129 | 45 | mean:60.0;unit:years | European, African unspecified, Hispanic or Latin American, East Asian, South Asian | null | USA | African unspecified=867, East Asian=167, European=11725, Hispanic or Latin American=799, South Asian=109 | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | PHB | null |
PSS000519 | PGS000013 | 9,070 | 4,658 | 4,412 | 59 | mean:68.0;unit:years | European, African unspecified | null | USA | African unspecified=1927, European=7143 | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | PMB | null |
PSS000520 | PGS000013 | 47,108 | 11,020 | 36,088 | 46.52 | mean:59.6;unit:years | European, African unspecified, Hispanic or Latin American, East Asian, South Asian | null | USA | African unspecified=9773, East Asian=167, European=29212, Hispanic or Latin America=7847, South Asian=109 | ICD-9 diagnosis code for acute myocardial infarction, other acute/subacute forms of ischemic heart disease, old myocardial infarction, other forms of chronic ischemic heart disease, certain unspecified sequelae of myocardial infarction, coronary bypass, or coronary revascularization (36.1, 36.2, 410, 411, 412, 414, 429... | null | null | null | null | PMB|PHB|BioMe | null |
PSS000521 | PGS000004, PGS000005, PGS000006 | 18,935 | 9,473 | 9,462 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000522 | PGS000004, PGS000005, PGS000006 | 13,401 | 3,263 | 10,138 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000523 | PGS000004, PGS000005, PGS000006 | 13,401 | 1,025 | 12,376 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000524 | PGS000351, PGS000352 | 18,935 | 2,068 | 16,867 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000525 | PGS000004, PGS000005, PGS000006 | 12,339 | 6,332 | 6,007 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000526 | PGS000004, PGS000005, PGS000006 | 8,752 | 703 | 8,049 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000527 | PGS000004, PGS000005, PGS000006 | 8,752 | 2,312 | 6,440 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
PSS000528 | PGS000351, PGS000352 | 12,339 | 718 | 11,621 | 0 | null | European | null | null | null | null | null | null | null | null | DEMOKRITOS|BCFR-NY|BCFR-PA|BCFR-UTAH|GC-HBOC|HEBCS|MSKCC|NC-BCFR|OFBCR|UCSF|MDACCS|CNIO|DKFZ|FCCC|G-FaST|IOVHBOCS|kConFab|MAYO|NCI|UPITT|SWE-BRCA|BCFR-AU|DFCI|EMBRACE|GEMO|HEBON|BFBOCC|BMBSA|BRICOH|CopBCS|COH|CONSIT_TEAM|Georgetown|HCSC|HUNBOCS|HUVH|ICO|IHCC|LUHR|INHERIT|KUMC|MCGILL|MUV|NNPIO|NSUHS|NRG_ONCOLOGY|OCGN|OU... | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.